SUBSCRIBE
SUBSCRIBE

Patient recruitment

Podcast
M&A Ticks Up, ASCO Excites and Vaccines Cause More Drama
Sanofi and BMS paid big money for rare disease and cancer assets, while Regeneron got in the obesity game; AstraZeneca, Gilead and Amgen shone at ASCO; RFK Jr. and the CDC appeared to disagree over COVID-19 vaccine recommendations and several news outlets are questioning the validity of the White House’s Make America Healthy Again report.
June 4, 2025
 · 
2 min read
 · 
Heather McKenzie
PRESS RELEASES
Press Releases
SNIPR BIOME Announces First Patient Dosed in its Phase 1b Clinical Trial of SNIPR001 in Patients with Hematological Cancer
June 12, 2025
 · 
3 min read
Press Releases
Secura Bio Announces First Patient Dosed in Phase 3 TERZO Study of COPIKTRA® (duvelisib) in Relapsed/Refractory Nodal T-follicular Helper Cell Lymphoma
June 9, 2025
 · 
5 min read
Press Releases
HistoSonics Completes Enrollment in #HOPE4KIDNEY Trial Evaluating Non-Invasive Histotripsy to Treat Kidney Tumors
June 9, 2025
 · 
4 min read
Press Releases
GenEditBio Announces First Patient Dosed in Investigator-Initiated Trial of GEB‑101, World’s First In Vivo CRISPR-Cas Ribonucleoprotein-Based Genome Editing Investigational Therapy for TGFBI Corneal Dystrophy
June 6, 2025
 · 
5 min read
Press Releases
Design Therapeutics Announces Start of Friedreich Ataxia Patient Dosing Ex-U.S. in its RESTORE-FA Phase 1/2 Multiple-Ascending Dose Trial of DT-216P2
June 5, 2025
 · 
6 min read
Press Releases
Biodexa Announces Recruitment of First Patient in Phase 2 Study of Tolimidone in Type 1 Diabetes
June 4, 2025
 · 
4 min read
Press Releases
Hemogenyx Pharmaceuticals PLC - Second Patient Passes Initial Safety Tests
June 3, 2025
 · 
3 min read
Press Releases
Curevo Enrolls First Participants in Phase 2 Extension Trial
June 2, 2025
 · 
2 min read
Press Releases
Syncromune® Announces First Patient Dosed in LEGION-100 Phase 2a Trial of SYNC-T® Therapy SV-102 for Patients with Metastatic Castration-Resistant Prostate Cancer
May 30, 2025
 · 
6 min read
Press Releases
uniQure Presents Clinical Case Study of First Patient Dosed with AMT-260 in Refractory Mesial Temporal Lobe Epilepsy (MTLE)
May 29, 2025
 · 
6 min read
Press Releases
BriaCell Bria-OTS™ Phase 1/2 Study Clears Safety Evaluation; Doses First Patient in Combination with Checkpoint Inhibitor
May 28, 2025
 · 
4 min read
Press Releases
Augustine Therapeutics announces first patient dosed in Phase I clinical trial evaluating lead candidate AGT-100216 for the treatment of Charcot-Marie-Tooth disease
May 27, 2025
 · 
3 min read
Press Releases
AnnJi Pharmaceutical Company Announces Positive Phase 1/2a Results for AJ201 in Spinal and Bulbar Muscular Atrophy (SBMA) Patients
May 22, 2025
 · 
4 min read
Press Releases
PeproMene Bio, Inc. and the Institute for Follicular Lymphoma Innovation (IFLI) Announce The First Follicular Lymphoma (FL) Patient Treated with BAFF-R Targeting CAR-T Cells (PMB-CT01) Achieves a Complete Response
May 21, 2025
 · 
4 min read
Press Releases
Minghui Pharmaceutical Announces First Patient Dosed in the Phase Ⅱ Combination Study of PD-1xVEGF Bispecific and TROP-2 ADC in Advanced NSCLC
May 20, 2025
 · 
4 min read
Press Releases
SELLAS Life Sciences Announces First Pediatric AML Patient Dosed in the Ongoing Phase 2 Trial of SLS009 r/r AML
May 16, 2025
 · 
4 min read
Press Releases
BioVie Enrolls First Patient in ADDRESS-LC Clinical Trial Assessing Novel Anti-Inflammatory Candidate Bezisterim for the Treatment of Neurological Symptoms Associated with Long COVID
May 15, 2025
 · 
9 min read
Press Releases
START Doses First U.S. Patient in Moderna’s Phase 1 Clinical Trial of mRNA-4106, a Pan-Tumor Antigen Therapy Candidate, in Solid Tumors
May 15, 2025
 · 
2 min read
Press Releases
AviadoBio Announces ASPIRE-FTD Phase 1/2 Clinical Trial in the UK at Cambridge University Hospitals NHS Foundation Trust, Cardiff and Vale University Health Board, and University College London
May 15, 2025
 · 
6 min read
Press Releases
EnGeneIC launches groundbreaking new Australian trial for innovative cancer therapy, with international trial site in Singapore to follow
May 13, 2025
 · 
3 min read
Load More